Posts by: Carolina Henriques

Carolina Henriques

Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

September 8, 2016September 8, 2016

New Lung Analysis Platform Rapidly Identifies Patients Eligible for Endobronchial Valve Treatment

Emphysema, News

Pulmonx recently announced that its StratX Lung Analysis Platform is commercially available in countries requiring CE mark (Conformité Européne, a mark that proves a product complies with the essential requirements ... Read more

August 30, 2016August 30, 2016

Clinicians Debate Management, Diagnosis of Respiratory Illnesses in Middle East

Asthma, COPD, Idiopathic Pulmonary Fibrosis, News

Leading medical professionals of European, Middle Eastern and African countries gathered at Boehringer Ingelheim’s second regional respiratory forum, themed “Innovative Solutions to Help Millions,” in Dubai to debate the clinical practices of ... Read more

August 29, 2016August 29, 2016

Boehringer Ingelheim and Duke Research Institute Expand IPF Patient Registry

News

Boehringer Ingelheim Pharmaceuticals and the Duke Clinical Research Institute (DCRI) are expanding the Idiopathic Pulmonary Fibrosis PROspective Outcomes Registry (IPF-PRO), which they say will make it the largest IPF patient registry in the country. The ... Read more

August 26, 2016August 26, 2016

Vanderbilt’s IPF Researchers Awarded $11M Grant to Study Genetics of Disease

Idiopathic Pulmonary Fibrosis, News

The National Heart, Lung and Blood Institute (NHLBI) has awarded Vanderbilt University Medical Center (VUMC) an $11 million project renewal grant to study the genetics and biological mechanisms behind idiopathic pulmonary ... Read more

August 19, 2016August 19, 2016

National Asthma and Lung Groups Collaborate to Empower Patients, Raise Awareness About Disease Severity

Asthma, News

The Allergy & Asthma Network recently partnered with the CHEST Foundation for a joint campaign to empower patients with persistent, difficult-to-control asthma. The campaign hopes to increase patients’ understanding of their condition through special ... Read more

August 11, 2016August 11, 2016

New Lung Disease Scanning Technology Has Potential to Transform Standard Treatment

Cystic Fibrosis, News

A new lung scanning technology with the potential to transform the treatment of people suffering from lung disease was developed by researchers at Monash University in Australia. The four-dimensional lung scanning platform ... Read more

August 2, 2016August 2, 2016

Trial Launches to Evaluate Ofev on IPF-Predicting Biomarkers

Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim Pharmaceuticals announced the launch of a new clinical trial to investigate the effects of Ofev (nintedanib) on certain blood biomarkers that might help identify fibrosis and loss of lung function ... Read more

July 22, 2016July 22, 2016

1 in 12 in Cancer Patients Seen to Develop a Secondary Cancer in Long Term, Especially in Lungs

Lung Cancer, News

A study of long-term outcomes in cancer patients found that nearly 1 in every 12 go on to develop other, unrelated cancers, especially lung cancer. According to researchers at the University of California in Los ... Read more

July 21, 2016July 21, 2016

FDA Grants Fast Track Status to Cystic Fibrosis Therapy QR-010 by ProQR

Cystic Fibrosis, News

ProQR Therapeutics announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its molecule QR-010 for the treatment of cystic fibrosis (CF) patients who have the deltaF508 mutation in ... Read more

July 20, 2016July 20, 2016

Eiger Doses First Patient in Phase 2 Trial of PAH Therapy Candidate Bestatin

News, Pulmonary Hypertension

Eiger BioPharmaceuticals has dosed the first patient in its Phase 2 LIBERTY study with the company’s product candidate ubenimex (Bestatin). The trial will assess Bestatin’s effects when added to standard of care treatment in people ... Read more